Wealthspire Advisors (Maryland)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-528
Closed -$16K 1551
2019
Q1
$16K Sell
528
-310
-37% -$8.88K ﹤0.01% 1364
2018
Q4
$26K Buy
838
+34
+4% +$1.24K ﹤0.01% 1111
2018
Q3
$30K Buy
804
+4
+0.5% +$151 ﹤0.01% 1153
2018
Q2
$31K Sell
800
-200
-20% -$6.74K ﹤0.01% 1143
2018
Q1
$34K Buy
1,000
+194
+24% +$7.44K ﹤0.01% 1126
2017
Q4
$36K Buy
806
+71
+10% +$3.23K ﹤0.01% 1133
2017
Q3
$37K Buy
735
+184
+33% +$9.4K ﹤0.01% 1082
2017
Q2
$29K Buy
551
+372
+208% +$19.9K ﹤0.01% 1134
2017
Q1
$10K Hold
179
﹤0.01% 1348
2016
Q4
$9K Sell
179
-136
-43% -$6.56K ﹤0.01% 1259
2016
Q3
$15K Hold
315
﹤0.01% 1142
2016
Q2
$17K Sell
315
-70
-18% -$3.86K ﹤0.01% 1048
2016
Q1
$21K Sell
385
-40
-9% -$1.97K ﹤0.01% 961
2015
Q4
$22K Buy
+425
New +$21.1K ﹤0.01% 937

Other funds holding PBH

Wealthspire Advisors (Maryland)'s PBH Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Prestige Consumer Healthcare (PBH) in Q2 2019, closing a stake of 528 shares — an estimated $16K sold.

Wealthspire Advisors (Maryland) first reported a position in PBH in Q4 2015 and held it in 14 quarters. The position peaked at $37K in Q3 2017. 212 funds tracked by Wall St. Rank hold PBH as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Prestige Consumer Healthcare position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 528 Prestige Consumer Healthcare shares in Q2 2019, an estimated $16K.
  • Wealthspire Advisors (Maryland) first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Prestige Consumer Healthcare position peaked at $37K in Q3 2017.
  • 212 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.